- Report
- November 2026
- 295 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- February 2026
- 250 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- May 2026
- 138 Pages
Global
From €3737EUR$3,999USD£3,122GBP
- Report
- April 2026
- 150 Pages
North America
From €3737EUR$3,999USD£3,122GBP
- Report
- September 2026
- 190 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- May 2026
- 400 Pages
Global
From €4624EUR$4,949USD£3,863GBP
- Report
- August 2026
- 110 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 160 Pages
Global
From €3102EUR$3,320USD£2,592GBP
€3878EUR$4,150USD£3,239GBP
- Report
- September 2026
- 184 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 192 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 186 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 186 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 197 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 188 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 191 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 195 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 199 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 180 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- September 2026
- 198 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- January 2026
- 194 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more